10.5281/zenodo.5061682
https://zenodo.org/records/5061682
oai:zenodo.org:5061682
Alshafie, Walaa
Walaa
Alshafie
0000-0001-7999-1297
Montreal Neurological Institute
Fotouhi, Maryam
Maryam
Fotouhi
0000-0001-8937-4719
Montreal Neurological Institute
Shlaifer, Irina
Irina
Shlaifer
0000-0002-3737-268X
Montreal Neurological Institute
Durcan, Thomas M.
Thomas M.
Durcan
0000-0003-3942-1956
Montreal Neurological Institute
McPherson, Peter S.
Peter S.
McPherson
0000-0001-7806-5662
Montreal Neurological Institute
Laflamme, Carl
Carl
Laflamme
0000-0001-5906-025X
Montreal Neurological Institute
Antibody Characterization Report for Serine/threonine-protein kinase TBK1
Zenodo
2021
Serine/threonine-protein kinase TBK1
TBK1
tbk1
NF-kappa-B-activating kinase
T2K
TANK-binding kinase 1
NAK
Q9UHD2
antibody characterization
antibody validation
Amyotrophic lateral sclerosis
ALS-RAP
2021-07-02
eng
10.5281/zenodo.5061681
https://zenodo.org/communities/sgc-opennotebook
https://zenodo.org/communities/openlabnotebooks
https://zenodo.org/communities/ycharos
Creative Commons Attribution 4.0 International
Head to head comparison of available commercial antibodies against Serine/threonine-protein kinase TBK1 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAPÂ was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.